Acute effects of lisdexamfetamine and D-amphetamine on social cognition and cognitive performance in a placebo-controlled study in healthy subjects
- PMID: 29511807
- DOI: 10.1007/s00213-018-4849-0
Acute effects of lisdexamfetamine and D-amphetamine on social cognition and cognitive performance in a placebo-controlled study in healthy subjects
Abstract
Rationale: Amphetamines are used as medications but are also misused as cognitive enhancers by healthy subjects and may have additional effects on social cognition.
Methods: We investigated the acute effects of single, high, equimolar doses of D-amphetamine (40 mg) and lisdexamfetamine (100 mg) on social cognition and cognitive performance using a randomized, placebo-controlled, double-blind, cross-over design in 24 healthy volunteers. Effects on social cognition were assessed using the Facial Emotion Recognition Task (FERT), Multifaceted Empathy Test (MET), and Sexual Arousal Task (SAT). Cognitive performance was measured using the Digit Symbol Substitution Test (DSST), Digit Span (DS), Stop-Signal Task (SST), and Mackworth Clock Test (MCT).
Results: D-Amphetamine and lisdexamfetamine had small effects on measures of social cognition. There were no effects on emotion recognition on the FERT. D-Amphetamine increased direct empathy on the MET, but only for positive stimuli. Both amphetamines increased ratings of pleasantness and attractiveness on the SAT in response to sexual but also to neutral stimuli. D-Amphetamine and lisdexamfetamine increased cognitive performance (go-accuracy and vigilance on the SST and MCT, respectively). Lisdexamfetamine increased processing speed on the DSST. Neither drug had an effect on the DS.
Conclusion: Single, high, equimolar doses of D-amphetamine and lisdexamfetamine enhanced certain aspects of cognitive performance in healthy non-sleep-deprived subjects. Both amphetamines also slightly altered aspects of social cognition. Whether these small effects also influence social interaction behavior in amphetamine users remains to be investigated.
Trial registration: The study was registered at ClinicalTrials.gov (NCT02668926).
Keywords: Cognitive performance; D-Amphetamine; Lisdexamfetamine; Sexual arousal; Social cognition.
Similar articles
-
Effects of lisdexamfetamine on plasma steroid concentrations compared with d-amphetamine in healthy subjects: A randomized, double-blind, placebo-controlled study.J Steroid Biochem Mol Biol. 2019 Feb;186:212-225. doi: 10.1016/j.jsbmb.2018.10.016. Epub 2018 Oct 28. J Steroid Biochem Mol Biol. 2019. PMID: 30381248 Clinical Trial.
-
A phase 1, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and pharmacokinetics of single and multiple doses of lisdexamfetamine dimesylate in Japanese and Caucasian healthy adult subjects.Neuropsychopharmacol Rep. 2020 Mar;40(1):16-29. doi: 10.1002/npr2.12082. Epub 2019 Nov 25. Neuropsychopharmacol Rep. 2020. PMID: 31765110 Free PMC article. Clinical Trial.
-
Alcohol acutely enhances decoding of positive emotions and emotional concern for positive stimuli and facilitates the viewing of sexual images.Psychopharmacology (Berl). 2017 Jan;234(1):41-51. doi: 10.1007/s00213-016-4431-6. Epub 2016 Sep 19. Psychopharmacology (Berl). 2017. PMID: 27640999 Clinical Trial.
-
Lisdexamfetamine.Paediatr Drugs. 2007;9(2):129-35; discussion 136-8. doi: 10.2165/00148581-200709020-00007. Paediatr Drugs. 2007. PMID: 17407369 Review.
-
Preclinical pharmacokinetics, pharmacology and toxicology of lisdexamfetamine: a novel d-amphetamine pro-drug.Neuropharmacology. 2014 Dec;87:41-50. doi: 10.1016/j.neuropharm.2014.02.014. Epub 2014 Mar 1. Neuropharmacology. 2014. PMID: 24594478 Review.
Cited by
-
Large-scale brain connectivity changes following the administration of lysergic acid diethylamide, d-amphetamine, and 3,4-methylenedioxyamphetamine.Mol Psychiatry. 2025 Apr;30(4):1297-1307. doi: 10.1038/s41380-024-02734-y. Epub 2024 Sep 11. Mol Psychiatry. 2025. PMID: 39261671 Free PMC article. Clinical Trial.
-
MDMA enhances positive affective responses to social feedback.J Psychopharmacol. 2024 Mar;38(3):297-304. doi: 10.1177/02698811231224153. Epub 2024 Jan 27. J Psychopharmacol. 2024. PMID: 38279662 Free PMC article. Clinical Trial.
-
Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects.Neuropsychopharmacology. 2020 Feb;45(3):462-471. doi: 10.1038/s41386-019-0569-3. Epub 2019 Nov 16. Neuropsychopharmacology. 2020. PMID: 31733631 Free PMC article.
-
Safety and cognitive pharmacodynamics following dose escalations with 3-methylmethcathinone (3-MMC): a first in human, designer drug study.Neuropsychopharmacology. 2025 Jun;50(7):1084-1092. doi: 10.1038/s41386-024-02042-7. Epub 2024 Dec 24. Neuropsychopharmacology. 2025. PMID: 39719487 Free PMC article. Clinical Trial.
-
Which came first: Cannabis use or deficits in impulse control?Prog Neuropsychopharmacol Biol Psychiatry. 2021 Mar 2;106:110066. doi: 10.1016/j.pnpbp.2020.110066. Epub 2020 Aug 11. Prog Neuropsychopharmacol Biol Psychiatry. 2021. PMID: 32795592 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous